Related Experiment Videos

Response to: 'Elephant in the room' by Hartung et al

Rohit Aggarwal¹, Chester V Oddis¹

¹Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Annals of the Rheumatic Diseases

|February 24, 2018

Abstract

No abstract available in PubMed .

Keywords:

dermatomyositis polymyositis treatment

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-Term Safety and Efficacy of Dazukibart in Dermatomyositis: Combined Phase II Results From Double-Blind and Open-Label Extension Studies.

The Journal of rheumatology·2026

Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association With Patient-Reported Outcomes.

The Journal of rheumatology·2026

Patient reports of evaluations for interstitial lung disease in patients with connective tissue diseases and rheumatoid arthritis: an international survey.

Respiratory research·2026

Defining interstitial lung disease related to idiopathic inflammatory myopathies: a systematic review protocol of the Myositis Clinical Trial Consortium (MCTC).

Systematic reviews·2026

Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.

Clinical, cosmetic and investigational dermatology·2026

Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathies.

Best practice & research. Clinical rheumatology·2026

See all related articles